IGC PHARMA, INC. (IGC) Operating cash flow 2016–2025
IGC PHARMA, INC. (IGC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.8MFY2025 · since FY2016: -$157,702 → -$4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.8M | +7.8% |
| FY2024 | -$5.2M | +26.2% |
| FY2023 | -$7.0M | +5.6% |
| FY2022 | -$7.5M | +30.9% |
| FY2021 | -$10.8M | -24.5% |
| FY2020 | -$8.7M | -160.6% |
| FY2019 | -$3.3M | -72.4% |
| FY2018 | -$1.9M | -38.8% |
| FY2017 | -$1.4M | -782.1% |
| FY2016 | -$157,702 | — |
Source: SEC XBRL filings · For reference only · Not investment advice